Fortress Biotech (FBIO)
Sources, funds and advances drug assets through a portfolio-company network.
$2.42
vs last close+0.01 (+0.41%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 17.37% | 5.79M shares | |
|---|---|---|---|
| 60 holders · as of Jun 30, 2026 | |||
| Insiders | 34.76% | 11.59M shares | |
| 9 holders · as of Jun 24, 2026 | |||
| Strategic holders | 13.53% | 4.51M shares | |
| 2 holders · as of Sep 1, 2026 | |||
| Other | 34.34% | 11.45M shares | |
| remainder | |||
33.35M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
60 holders · 5.79M shares · 14 new positions · 27 increased · 17 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.04M | 3.11% | +71.2K | Aug 13, 2026 |
| Opaleye Management Inc. | 890.0K | 2.67% | −152.0K | Aug 14, 2026 |
| Mackenzie Financial Corp | 555.7K | 1.67% | +555.7Knew | Aug 13, 2026 |
| Gsa Capital Partners LLP | 458.5K | 1.37% | +204.3K | Aug 6, 2026 |
| Shikiar Asset Management Inc | 305.5K | 0.92% | 0 | Jul 21, 2026 |
| Geode Capital Management, LLC | 300.5K | 0.90% | +10.3K | Aug 12, 2026 |
| BlackRock, Inc. | 224.8K | 0.67% | +27.7K | Aug 7, 2026 |
| Two Sigma Investments, LP | 213.8K | 0.64% | +17.0K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | 20.70% | 6.92M | 13D | Mar 20, 2026 |
| Highbridge Capital Management, LLC | 9.00% | 2.73M | 13G | Oct 25, 2024 |
| Integrated Core Strategies (US) LLC | 5.30% | 1.78M | 13G | Sep 1, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.